Efficacy and Safety of Apremilast in Patients With Genital Psoriasis: Results From the Phase 3, Randomized, Placebo-Controlled, Double-blind DISCREET Study. (2023). SKIN The Journal of Cutaneous Medicine, 7(2), s110. https://doi.org/10.25251/skin.7.supp.110